[HTML][HTML] Beyond CD19: opportunities for future development of targeted immunotherapy in pediatric relapsed-refractory acute leukemia

H Shalabi, A Angiolillo, TJ Fry - Frontiers in Pediatrics, 2015 - frontiersin.org
Chimeric antigen receptor (CAR) T cell therapy has been used as a targeted approach in
cancer therapy. Relapsed and refractory acute leukemia in pediatrics has been difficult to …

[HTML][HTML] Spectrum and immunophenotypic profile of acute leukemia: a tertiary center flow cytometry experience

N Gupta, R Pawar, S Banerjee, S Brahma… - … journal of hematology …, 2019 - ncbi.nlm.nih.gov
Spectrum and Immunophenotypic Profile of Acute Leukemia: A Tertiary Center Flow Cytometry
Experience - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

[HTML][HTML] Aberrant immunophenotypes in acute lymphoblastic leukemia

ME Cuéllar-Mendoza, FR Chávez-Sánchez… - Boletín médico del …, 2020 - scielo.org.mx
Acute lymphoblastic leukemia (ALL) is the most prevalent hematologic neoplasia worldwide.
To classify leukemia, we analyzed the immunophenotypic characteristics in the neoplastic …

Flowcytometric immunophenotypic profile of acute leukemia: mansoura experience

DA Salem, SM Abd El-Aziz - Indian journal of hematology and blood …, 2012 - Springer
Acute leukemia (AL) displays characteristic patterns of antigen expression, which facilitate
their identification and proper classification. The purpose of this study is to evaluate the …

Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy

PS Chauhan, B Bhushan, LC Singh, AK Mishra… - … and molecular pathology, 2012 - Elsevier
Resistance to chemotherapy is a major impediment to the successful treatment of acute
leukemia (AL). Expression of genes involved in drug resistance and apoptosis may be …

[HTML][HTML] Expression of aberrant antigens in hematological malignancies: A single center experience

A Shahni, M Saud, S Siddiqui… - Pakistan journal of …, 2018 - ncbi.nlm.nih.gov
Methods: One milliliter peripheral blood or bone marrow samples were analyzed on FACS
Calibur flowcytometer. The cells were lysed and stained following standard protocol. Data …

[HTML][HTML] Immunophenotypic characteristics of T lineage acute lymphoblastic leukemia: absence of immaturity markers-TdT, CD34 and HLADR is not uncommon

R Gupta, N Garg, M Kotru, D Kumar… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Introduction: T ALL may show variable morphological features and immunophenotypic
analysis for characterisation of immature nature of these cells is needed to establish a …

Clinical significance of co-expression of aberrant antigens in acute leukemia: a retrospective cohort study in Makah Al Mukaramah, Saudi Arabia

NAB Abdulateef, MM Ismail… - Asian Pacific Journal of …, 2014 - koreascience.kr
Background: Aberrant phenotypes in acute leukemia have variable frequency and their
prognostic and predictive relevance is controversial, despite several reports of clinical …

[HTML][HTML] Characterization of immunophenotypic aberrancies in adult and childhood acute lymphoblastic leukemia: A study from Northern India

M Sharma, MUS Sachdeva, N Varma… - Journal of cancer …, 2016 - journals.lww.com
Background: Identification of aberrant antigen expression is important in characterizing
neoplastic population among non. neoplastic bone marrow counterparts and further in the …

[HTML][HTML] Aberrant phenotype in Iranian patients with acute myeloid leukemia

M Jahedi, K Shamsasenjan, Z Sanaat… - Advanced …, 2014 - ncbi.nlm.nih.gov
Purpose: The aim of this study was to evaluate the incidence of aberrant phenotypes and
possible prognostic value in peripheral and bone marrow blood mononuclear cells of …